Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Medtronic
McKesson
Express Scripts
Harvard Business School

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 9,775,904

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,775,904
Title:Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists
Abstract: The present invention relates to dual GLP-1/glucagon receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.
Inventor(s): Bossart; Martin (Frankfurt am Main, DE), Elvert; Ralf (Frankfurt am Main, DE), Evers; Andreas (Frankfurt am Main, DE), Haack; Torsten (Frankfurt am Main, DE), Stengelin; Siegfried (Frankfurt am Main, DE), Wagner; Michael (Frankfurt am Main, DE)
Assignee: SANOFI (Paris, FR)
Application Number:14/679,743
Patent Claims:see list of patent claims

Details for Patent 9,775,904

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Eli Lilly And Co TRULICITY dulaglutide INJECTABLE;INJECTION 125469 002 2015-03-09   Start Trial SANOFI (Paris, FR) 2034-04-07 RX search
Eli Lilly And Co TRULICITY dulaglutide INJECTABLE;INJECTION 125469 001 2015-03-09   Start Trial SANOFI (Paris, FR) 2034-04-07 RX search
Glaxosmithkline Llc TANZEUM albiglutide INJECTABLE;INJECTION 125431 001 2014-04-15   Start Trial SANOFI (Paris, FR) 2034-04-07 RX search
Aegerion MYALEPT metreleptin INJECTABLE;INJECTION 125390 001 2014-02-24   Start Trial SANOFI (Paris, FR) 2034-04-07 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
McKesson
AstraZeneca
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.